Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support

Author:

Radford Michael12,Estcourt Lise J34,Sirotich Emily5,Pitre Tyler6,Britto Joanne7,Watson Megan6,Brunskill Susan J48,Fergusson Dean A9,Dorée Carolyn48,Arnold Donald M1011

Affiliation:

1. McMaster Centre for Transfusion Research; McMaster University; Hamilton Canada

2. Department of Oncology; Hamilton Health Sciences Centre; Hamilton Canada

3. Haematology/Transfusion Medicine; NHS Blood and Transplant; Oxford UK

4. Nuffield Department of Clinical Laboratory Sciences; University of Oxford; Oxford UK

5. Medicine; Yale School of Medicine; New Haven Connecticut USA

6. Medicine; University of Toronto; Toronto Canada

7. Oncology; Hamilton Health Sciences Centre; Hamilton Canada

8. Systematic Review Initiative; NHS Blood and Transplant; Oxford UK

9. Clinical Epidemiology Program; Ottawa Hospital Research Institute; Ottawa Canada

10. Division of Hematology and Thromboembolism, Department of Medicine; McMaster University; Ontario Canada

11. McMaster University; Hamilton Canada

Publisher

Wiley

Reference168 articles.

1. A prospective randomized study for optimal red blood cell use patients with acute myeloid leukemia receiving dose intensive chemotherapy;Byun;Blood,2022

2. A prospective randomized study for optimal use of red blood cell transfusion in patients with acute myeloid leukemia receiving intensive chemotherapy;Byun;Blood Transfusion,2023

3. A prospective randomized study for optimal use of red blood cell transfusion in patients with acute myeloid leukemia receiving intensive chemotherapy;Byun;Blood Transfusion,2023

4. De Zern AE King K Hand W Levis M Smith BD Liberal vs. restrictive transfusion thresholds in leukemia patients: a feasibility pilot study American Society of Hematology (ASH), the 57th Annual meeting & exposition, Orlando

5. Red blood cell transfusion triggers in acute leukemia: a randomized pilot study;De Zern;Transfusion,2016

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3